Amgen olpasiran may fill critical treatment gap in lowering Lp(a): GlobalData
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
Centre aims to train surgeons and other healthcare professionals from India and Southeast Asia in robotic-assisted surgery
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Subscribe To Our Newsletter & Stay Updated